BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12821717)

  • 61. Phosphorylation of NF-kappaB1/p105 by oncoprotein kinase Tpl2: implications for a novel mechanism of Tpl2 regulation.
    Babu GR; Jin W; Norman L; Waterfield M; Chang M; Wu X; Zhang M; Sun SC
    Biochim Biophys Acta; 2006 Feb; 1763(2):174-81. PubMed ID: 16448710
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low intensity pulsed ultrasound (LIPUS) influences the multilineage differentiation of mesenchymal stem and progenitor cell lines through ROCK-Cot/Tpl2-MEK-ERK signaling pathway.
    Kusuyama J; Bandow K; Shamoto M; Kakimoto K; Ohnishi T; Matsuguchi T
    J Biol Chem; 2014 Apr; 289(15):10330-10344. PubMed ID: 24550383
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The tyrosine kinase Syk regulates TPL2 activation signals.
    Eliopoulos AG; Das S; Tsichlis PN
    J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phosphorylation of threonine 290 in the activation loop of Tpl2/Cot is necessary but not sufficient for kinase activity.
    Luciano BS; Hsu S; Channavajhala PL; Lin LL; Cuozzo JW
    J Biol Chem; 2004 Dec; 279(50):52117-23. PubMed ID: 15466476
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cot/tpl2 participates in the activation of macrophages by adiponectin.
    Sanz-Garcia C; Nagy LE; Lasunción MA; Fernandez M; Alemany S
    J Leukoc Biol; 2014 Jun; 95(6):917-30. PubMed ID: 24532642
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor-activated macrophages.
    López-Pelaéz M; Fumagalli S; Sanz C; Herrero C; Guerra S; Fernandez M; Alemany S
    Mol Biol Cell; 2012 Aug; 23(15):2982-92. PubMed ID: 22675026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. TPL2 meets p38MAPK: emergence of a novel positive feedback loop in inflammation.
    Menon MB; Gaestel M
    Biochem J; 2016 Oct; 473(19):2995-9. PubMed ID: 27679858
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cot/tpl2 (MAP3K8) mediates myeloperoxidase activity and hypernociception following peripheral inflammation.
    Soria-Castro I; Krzyzanowska A; Pelaéz ML; Regadera J; Ferrer G; Montoliu L; Rodríguez-Ramos R; Fernández M; Alemany S
    J Biol Chem; 2010 Oct; 285(44):33805-15. PubMed ID: 20736176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tpl2 and ERK transduce antiproliferative T cell receptor signals and inhibit transformation of chronically stimulated T cells.
    Tsatsanis C; Vaporidi K; Zacharioudaki V; Androulidaki A; Sykulev Y; Margioris AN; Tsichlis PN
    Proc Natl Acad Sci U S A; 2008 Feb; 105(8):2987-92. PubMed ID: 18287049
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Advancement in TPL2-regulated innate immune response.
    Yan MH; Hao JH; Zhang XG; Shen CC; Zhang DJ; Zhang KS; Zheng HX; Liu XT
    Immunobiology; 2019 May; 224(3):383-387. PubMed ID: 30853309
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice.
    Kyrmizi I; Ioannou M; Hatziapostolou M; Tsichlis PN; Boumpas DT; Tassiulas I
    J Leukoc Biol; 2013 Oct; 94(4):751-7. PubMed ID: 23898046
    [TBL] [Abstract][Full Text] [Related]  

  • 72. TPL2 kinase action and control of inflammation.
    Xu D; Matsumoto ML; McKenzie BS; Zarrin AA
    Pharmacol Res; 2018 Mar; 129():188-193. PubMed ID: 29183769
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tpl-2/Cot and COX-2 in breast cancer.
    Krcova Z; Ehrmann J; Krejci V; Eliopoulos A; Kolar Z
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2008 Jun; 152(1):21-5. PubMed ID: 18795070
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Interleukin-1 stimulated activation of the COT catalytic subunit through the phosphorylation of Thr290 and Ser62.
    Stafford MJ; Morrice NA; Peggie MW; Cohen P
    FEBS Lett; 2006 Jul; 580(16):4010-4. PubMed ID: 16806191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TPL2 mediates IL-17R signaling in neuroinflammation.
    Xiao Y; Sun SC
    Oncotarget; 2015 Sep; 6(26):21789-90. PubMed ID: 26318043
    [No Abstract]   [Full Text] [Related]  

  • 76. The Potential Role of RP105 in Regulation of Inflammation and Osteoclastogenesis During Inflammatory Diseases.
    Fan Z; Pathak JL; Ge L
    Front Cell Dev Biol; 2021; 9():713254. PubMed ID: 34414191
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emerging roles of immunostimulatory oral bacteria in periodontitis development.
    Jiao Y; Hasegawa M; Inohara N
    Trends Microbiol; 2014 Mar; 22(3):157-63. PubMed ID: 24433922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Differential expression of mitogen activating protein kinases in periodontitis.
    Travan S; Li F; D'Silva NJ; Slate EH; Kirkwood KL
    J Clin Periodontol; 2013 Aug; 40(8):757-64. PubMed ID: 23742695
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.
    Kuroda Y; Hisatsune C; Mizutani A; Ogawa N; Matsuo K; Mikoshiba K
    Mol Cell Biol; 2012 Jul; 32(14):2954-63. PubMed ID: 22615493
    [TBL] [Abstract][Full Text] [Related]  

  • 80. CXCL13 activation of c-Myc induces RANK ligand expression in stromal/preosteoblast cells in the oral squamous cell carcinoma tumor-bone microenvironment.
    Sambandam Y; Sundaram K; Liu A; Kirkwood KL; Ries WL; Reddy SV
    Oncogene; 2013 Jan; 32(1):97-105. PubMed ID: 22330139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.